Hepatocellular carcinoma (HCC) arises on a background of chronic injury and cirrhosis in most patients and features recurrent activation of the IGF axis, with elevated ligand signaling and IGF-1R pathway engagement repeatedly implicated in tumor initiation, maintenance, and therapeutic vulnerability [109]. The gene discussed is IGF1; the disease is hepatocellular carcinoma.